SecSonar.com

TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

TherapeuticsMD, Inc. (TXMD) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $24.2M. Revenue grew 71.6% year-over-year and the company generated $2.4M in free cash flow. This page tracks TXMD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1 employees · IPO May 9, 2007

Valuation

Valuation & price

$2.00 · as of May 17, 2026 · -27.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.90

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.61$1.82$1.04Jul 25Dec 25Jul 26Jul 7, 25$1.17Jul 9, 25$1.22Jul 11, 25$1.18Jul 15, 25$1.14Jul 17, 25$1.15Jul 21, 25$1.16Jul 23, 25$1.20Jul 25, 25$1.19Jul 29, 25$1.16Jul 31, 25$1.12Aug 4, 25$1.10Aug 6, 25$1.11Aug 11, 25$1.08Aug 13, 25$1.16Aug 15, 25$1.17Aug 19, 25$1.16Aug 21, 25$1.08Aug 25, 25$1.11Aug 27, 25$1.12Aug 29, 25$1.11Sep 3, 25$1.11Sep 5, 25$1.08Sep 9, 25$1.08Sep 11, 25$1.11Sep 16, 25$1.08Sep 18, 25$1.08Sep 22, 25$1.08Sep 24, 25$1.08Sep 26, 25$1.07Sep 30, 25$1.08Oct 2, 25$1.06Oct 6, 25$1.05Oct 8, 25$1.06Oct 10, 25$1.04Oct 14, 25$1.04Oct 16, 25$1.05Oct 21, 25$1.17Oct 23, 25$1.31Oct 27, 25$1.31Oct 29, 25$1.21Oct 31, 25$1.19Nov 4, 25$1.17Nov 6, 25$1.27Nov 10, 25$1.35Nov 12, 25$1.68Nov 14, 25$1.96Nov 18, 25$1.54Nov 20, 25$1.92Nov 25, 25$1.62Nov 28, 25$1.70Dec 2, 25$1.46Dec 4, 25$1.61Dec 8, 25$1.66Dec 10, 25$1.88Dec 12, 25$1.75Dec 16, 25$1.62Dec 18, 25$1.67Dec 22, 25$1.68Dec 24, 25$1.70Dec 29, 25$1.68Jan 2, 26$1.65Jan 6, 26$2.04Jan 8, 26$2.06Jan 12, 26$2.08Jan 14, 26$2.14Jan 16, 26$2.23Jan 21, 26$2.49Jan 23, 26$2.61Jan 27, 26$2.42Jan 29, 26$2.30Feb 2, 26$2.26Feb 4, 26$2.25Feb 9, 26$2.48Feb 11, 26$2.43Feb 13, 26$2.36Feb 18, 26$2.32Feb 20, 26$2.30Feb 24, 26$2.25Feb 26, 26$2.26Mar 2, 26$2.24Mar 4, 26$2.16Mar 6, 26$2.25Mar 10, 26$2.30Mar 12, 26$2.28Mar 17, 26$2.23Mar 19, 26$2.23Mar 23, 26$2.31Mar 25, 26$2.29Mar 27, 26$2.10Mar 31, 26$2.02Apr 2, 26$2.00Apr 7, 26$2.02Apr 9, 26$2.05Apr 13, 26$2.05Apr 15, 26$2.09Apr 17, 26$2.07Apr 22, 26$2.11Apr 24, 26$2.19Apr 28, 26$2.10Apr 30, 26$2.04May 4, 26$2.02May 6, 26$2.03May 8, 26$1.98May 12, 26$1.95May 14, 26$1.99May 18, 26$2.02May 20, 26$2.08May 22, 26$2.12May 28, 26$2.11Jun 1, 26$2.12Jun 3, 26$1.97Jun 5, 26$1.99Jun 9, 26$1.88Jun 11, 26$1.82Jun 15, 26$2.28Jun 17, 26$2.27Jun 22, 26$2.00Jun 24, 26$2.01Jun 26, 26$2.11Jul 2, 26$2.09
$1.0452-week range$2.77
Loading valuation history…

Fundamentals

Key fundamentals

$24.2M

Market cap

71.6%

Revenue growth (YoY)

100.0%

Gross margin

$2.4M

Free cash flow (USD)

-$2.4M

Net debt

Net cash position

0.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$19.4MFY 2017$16.8MFY 2018$16.1MFY 2019$49.6MFY 2020$64.9MFY 2021$2.6MFY 2022$70.0MFY 2023$1.3MFY 2024$1.8MFY 2025$3.0M
$19.4M$3M

Free cash flow by year

2016 → 2025

FY 2016$-70.4MFY 2017$-77.0MFY 2018$-128.1MFY 2019$-189.6MFY 2020$-161.1MFY 2021$-147.8MFY 2022$-4.4MFY 2023$-96.3MFY 2024$732.0KFY 2025$2.4M
-$70.4M$2.4M

Gross margin by year

2021 → 2025

FY 202145.5%FY 202298.0%FY 2023100.0%FY 2024100.0%FY 2025100.0%
45.5%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • Annual report10-K FiledApr 1, 2026Filing

Questions

Frequently asked questions

What is TherapeuticsMD, Inc.'s market cap?

TherapeuticsMD, Inc. (TXMD) has a market capitalization of $24.2M.

What is TXMD's P/E ratio?

A meaningful P/E ratio is not available for TXMD — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TXMD's price-to-book (P/B) ratio?

TXMD trades at 0.90 times book value per share.

Are insiders buying TXMD stock?

SEC Form 4 filings show no open-market insider buys at TherapeuticsMD, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

OPTH

Optimi Health Corp.

$19.6M

RMTI

Rockwell Medical, Inc.

$29.3M

AYTU

Aytu BioPharma, Inc.

$17.8M

TLPH

Talphera, Inc.

$16.3M

COSM

Cosmos Health Inc.

$13.9M

BFRI

Biofrontera Inc.

$11M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.